These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 8522591)

  • 1. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant.
    Ku NO; Michie S; Oshima RG; Omary MB
    J Cell Biol; 1995 Dec; 131(5):1303-14. PubMed ID: 8522591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant.
    Ku NO; Michie SA; Soetikno RM; Resurreccion EZ; Broome RL; Oshima RG; Omary MB
    J Clin Invest; 1996 Aug; 98(4):1034-46. PubMed ID: 8770877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.
    Ku NO; Soetikno RM; Omary MB
    Hepatology; 2003 May; 37(5):1006-14. PubMed ID: 12717381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity.
    Toivola DM; Omary MB; Ku NO; Peltola O; Baribault H; Eriksson JE
    Hepatology; 1998 Jul; 28(1):116-28. PubMed ID: 9657104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of human keratin 18 phosphorylation: polarized distribution of phosphorylated keratins in simple epithelial tissues.
    Liao J; Lowthert LA; Ku NO; Fernandez R; Omary MB
    J Cell Biol; 1995 Dec; 131(5):1291-301. PubMed ID: 8522590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.
    Kwan R; Chen L; Looi K; Tao GZ; Weerasinghe SV; Snider NT; Conti MA; Adelstein RS; Xie Q; Omary MB
    Hepatology; 2015 Dec; 62(6):1858-69. PubMed ID: 26126491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice.
    Ku NO; Michie SA; Soetikno RM; Resurreccion EZ; Broome RL; Omary MB
    J Cell Biol; 1998 Dec; 143(7):2023-32. PubMed ID: 9864372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation.
    Harada M; Strnad P; Resurreccion EZ; Ku NO; Omary MB
    Hepatology; 2007 Jan; 45(1):88-96. PubMed ID: 17187412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
    Snider NT; Weerasinghe SV; Iñiguez-Lluhí JA; Herrmann H; Omary MB
    J Biol Chem; 2011 Jan; 286(3):2273-84. PubMed ID: 21062750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and mutational analysis of the glycosylation sites of human keratin 18.
    Ku NO; Omary MB
    J Biol Chem; 1995 May; 270(20):11820-7. PubMed ID: 7538124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression.
    Ku NO; Michie S; Resurreccion EZ; Broome RL; Omary MB
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4373-8. PubMed ID: 11917136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury.
    Toivola DM; Nakamichi I; Strnad P; Michie SA; Ghori N; Harada M; Zeh K; Oshima RG; Baribault H; Omary MB
    Am J Pathol; 2008 Apr; 172(4):882-92. PubMed ID: 18349119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin modifications and solubility properties in epithelial cells and in vitro.
    Omary MB; Ku NO; Liao J; Price D
    Subcell Biochem; 1998; 31():105-40. PubMed ID: 9932491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, glycosylation, and phosphorylation of human keratins 8 and 18 in insect cells.
    Ku NO; Omary MB
    Exp Cell Res; 1994 Mar; 211(1):24-35. PubMed ID: 7510249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoskeletal keratin glycosylation protects epithelial tissue from injury.
    Ku NO; Toivola DM; Strnad P; Omary MB
    Nat Cell Biol; 2010 Sep; 12(9):876-85. PubMed ID: 20729838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion.
    Ku NO; Omary MB
    J Cell Biol; 2000 May; 149(3):547-52. PubMed ID: 10791969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbances in hepatic cell-cycle regulation in mice with assembly-deficient keratins 8/18.
    Toivola DM; Nieminen MI; Hesse M; He T; Baribault H; Magin TM; Omary MB; Eriksson JE
    Hepatology; 2001 Dec; 34(6):1174-83. PubMed ID: 11732007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8.
    Kulesh DA; Ceceña G; Darmon YM; Vasseur M; Oshima RG
    Mol Cell Biol; 1989 Apr; 9(4):1553-65. PubMed ID: 2471065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury.
    Tao GZ; Toivola DM; Zhong B; Michie SA; Resurreccion EZ; Tamai Y; Taketo MM; Omary MB
    J Cell Sci; 2003 Nov; 116(Pt 22):4629-38. PubMed ID: 14576356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with c-jun amino-terminal kinase activation and protein adduct formation.
    Guldiken N; Zhou Q; Kucukoglu O; Rehm M; Levada K; Gross A; Kwan R; James LP; Trautwein C; Omary MB; Strnad P
    Hepatology; 2015 Sep; 62(3):876-86. PubMed ID: 25963979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.